Become a member

Quick Registration

Full Registration Benefits -

Free Homepages for Doctors

Free Homepages for Hospitals

Free Homepages for Medical Conference

Free Homepages for NGO's

Personal Health Record Creation

Access to all Medical Slides

Access to all Jobs & Products Sale

Explore Medindia

Medindia » Press Release » Prime Therapeutics comments on Supreme Court ruling on healthcare reform law

Prime Therapeutics comments on Supreme Court ruling on healthcare reform law

6/28/2012 Drug News

June 28, 2012 "This is very good news for consumers, and as a company charged with helping our clients secure affordable medicine for customers, we are prepared to ensure a cost-effective, efficient individual market offering," said Eric Elliott, president and CEO of pharmacy benefit manager Prime Therapeutics. "Prime has spent the past two years preparing for the introduction of state-based health care exchanges and other PPACA provisions, and is encouraged by an outcome that supports these efforts and allows us to continue in executing on our strategy."

Prime Therapeutics is a pharmacy benefit management company dedicated to providing innovative, clinically-based, cost-effective pharmacy solutions for clients and customers. Providing pharmacy benefit services nationwide to nearly 20 million lives, its client base includes Blue Cross and Blue Shield Plans, employer and union groups, and third-party administrators. Headquartered in St. Paul, Minn., Prime Therapeutics is collectively owned by 13 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those Plans. Learn more at www.primetherapeutics.com. Follow Prime on Twitter @Prime_PBM.

SOURCE Prime Therapeutics

Email

RSS Feeds

Print

Save

Link

Syndicate

Comments

USW Lauds Supreme Court's Decision to Uphold ACA; Health Reform Fight Continues

MedInformatix Collaborates With Eye Center SEECA to Develop Artificial Intelligence to Quantify Patient Fitness for Refractive Surgery

Comment & Contribute

Be the first to comment * Your comment can be maximum of 2500 characters
	I agree to the terms and conditions
Your comments are automatically posted once they are submitted. All comments are however constantly reviewed for spam and irrelevant material (such as product or personal advertisements, email addresses, telephone numbers and website address). Such insertions do not conform to our policy and 'Terms of Use' and are either deleted or edited and republished. Please keep your comments brief and relevant.This section may also have questions seeking help. If you have the information you are welcome to respond, but please ensure that the information so provided is genuine and not misleading.